chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I am chair bound right now, I am recovering from Covid; I am chair bound right now, I am recovering from Covid; heart burns; arm swelled around the injection site; Arm swelled around the injection site and it hurts and burns; her arm swelled around the injection site and it was all red; arm day swell up all around the injection site and it was still hard; This is a spontaneous report from a contactable consumer (patient). A 85-years-old female patient received second dose BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation solution for injection, lot number unknown, expiration date unknown), via an unspecified route of administration administered in Arm on 19Feb2021 as single dose for covid-19 immunization. Medical history included ongoing hypertension. Patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation solution for injection, lot number EL3248, expiration date unknown), via an unspecified route of administration as single dose for covid-19 immunization 29Jan2021 and stated that she did not have a reaction after the first dose of the vaccine and she only had a slight rise of temperature after the first dose. The caller stated that after receiving the second dose of vaccine on Friday and on the next day on 20Feb2021 her arm swelled around the injection site and stated that it hurts, it burns, and it was all red and mentioned that it was still hard and red and painful, and she been putting ice on it, but it still was red, hard and it did not seem to have helped. On an unspecified date, she was also experiencing heart burns and further stated that she was chair bound right now and was recovering from Covid (considered as covid-19 and drug ineffective). Patient stated that blood work has not yet been ordered and they are going to come to her house to do it in her house, but they have not come yet. The outcome of events drug ineffective and COVID-19 was recovering, and outcome of the other events were unknown.  Information about batch/lot number has been requested.
Approximately 12 hours after 2nd vaccine - (along with the other expected usual vaccine symtoms told may get) I started cycling with severe pains in head on both sides in different location.  Electric shock like pains that start gradual (one per hour, and increase to maybe one every 5 mintues) . Lasted the weekend.  I have had it before. I have to take naproxen repeatedly until it goes away.  Anyways signals to me that I will likely get within a 2-6 week span a future sinus infection often accompanied by a severe upper respiratory tract like infection (cough that is productive and then gets drier / and also somewhat of a bronchial asthmatic cough (undiagnosed) that spasms coughing fit from certain smells / temperature changes that usually dont affect a normal day.    This is exactly what happened to me.  I became ill with these symptoms on November 26, 2021, and I had to call out of work for 5 days (most I have ever done in my life) Times are different and can't go to work and have a sniffle or a cough anymore either.  I am slowly recovering.  Still have most coughing spells in morning and at night.  Thought I was going to have to go to hospital (scarey) two nights ago as dry mucuous was covering partial airway - had to take shower and move around at 2 o'clock in morning to get it moving.  Likely will take a few more weeks to fully recover judging from past experience with this.  Used to get more of these when I was younger and prior to realizing I was allergic to peanuts / shrimp which i have since taken out of my diet.  The last time i had this was in 2017, when a lot of people were falling ill with some type of bad viral cold or flu that may have been going around that stirred up a sinus/upper respiratory infection.  Haven't been too sick since  until 12 hours after receiving the Pzifer vaccine.  Also the first vaccine stirred my vertigo for a day only so not too bad with the first vaccine.  Felt it was important to document  my reaction as the quality of my life is just as important as anyone else's (both receiving vaccine by choice or electing not to receive the vaccine.)  Also wouldn't get the other vaccines because I saw they contain citric acid.
Area of Induration Red, firm, slightly warm. No fever, no diarrhea, no vomiting. No other complaints. Child running and playing.
Felt lightheaded; Had difficulty walking; Arm was sore for weeks; Body was sore for over 1 month; This case was reported by a pharmacist and described the occurrence of light-headed feeling in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, less than a day after receiving Shingrix, the patient experienced light-headed feeling, walking difficulty, pain in arm and general body pain. On an unknown date, the outcome of the light-headed feeling and walking difficulty were unknown and the outcome of the pain in arm and general body pain were recovered/resolved.   It was unknown if the reporter considered the light-headed feeling, walking difficulty, pain in arm and general body pain to be related to Shingrix.  Additional information received were as follows: The age at vaccination was not reported. The patient had side effects. On the same evening at the vaccination, the patient felt lightheaded and had difficulty walking. Less than 2 years after receiving Shingrix, the patient's arm was sore for weeks and her body was sore for over 1 month. The reporter suggested to wait on the 2nd dose, until the reporter contacted Glaxosmithkline.
This spontaneous report was received from a lawyer regarding a case in litigation and refers to a patient of unknown age and gender. The patient's pertinent medical history, concurrent conditions or concomitant medications were not reported. In 2011, the patient was inoculated with ZOSTAVAX (dose, route, and lot # were not provided) at a school department for routine adult health maintenance and for the long-term prevention. It was mentioned that the vaccine did not prevent shingles as intended, and the patient subsequently contracted a persistent strain of herpes zoster or shingles. Later in 2016, the patient was treated at a dermatology department of a medical center for a blistering vesicular outbreak, which was diagnosed as herpes zoster or shingles. As a direct and proximate result of the ZOSTAVAX vaccine, and/or despite receiving ZOSTAVAX for long-term prevention of shingles, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and would continue to suffer significant medical expenses, and pain and suffering, and other damages. At the time of the report, the outcome of the aforementioned adverse events was unknown. The relatedness assessment between the aforementioned adverse events and ZOSTAVAX was related.
Joint pain, aching muscles unable to walk, tremors like seizure disorder, shortness of breath, severe chest pain, throat pain, severe neck pain sensible to touch, confusion, anxiety
Redness and swelling and pain at injection site.  Pt also stated it was a little hard at injection site also
Initial report received via search of the literature on 16 April 2013. This case contains information for 1 of 22 patients whose clinical data were provided. Information regarding the other 21 patients is captured in case numbers 2013-05188, 2013-05251-05258, 2013-05260-05263, 2013-05268-05269, 2006-03230, 1995-00224, 2003-02926, 2011-03827, 2006-03086 and 1995-00668. From the published article, the authors reviewed charts of patients who had been hospitalized with Guillain-Barre Syndrome (GBS) from 1995 through 2006. Using a case-centered design, they compared the odds of vaccination in the 6 and 10 weeks prior to onset of GBS to the odds of vaccination during the same time intervals in all vaccinated individuals in the entire hospital population. While cases of GBS had been reported following a wide range of vaccines, a clear association had only been established with the 1976 H1N1 inactivated influenza vaccine. The authors confirmed 415 cases of which only 25 had received any vaccine in the six weeks prior to GBS onset. Vaccines received included TIV, 23-valent polysaccharide pneumococcal vaccine, tetanus-diphtheria combination vaccines, Hepatitis A and Hepatitis B. The large retrospective study did not find any association between influenza vaccine or any other vaccine and the development of GBS within 6 weeks following vaccination. According to the authors, the risk of GBS following any vaccine, including influenza vaccines, was extremely low. Regarding this case which involved a 74-year-old male patient who had received Trivalent inactivated influenza vaccine (manufacturer unknown; lot number, route, site and date of administration not reported) and 25 days later reported the onset of GBS. No further information was provided. Outcomes were not reported. Documents held by sender: none.
My whole body was hurting and; Had slight headache; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 26-Oct-2021 and was forwarded to Moderna on 26-Oct-2021.    This spontaneous case was reported by a consumer and describes the occurrence of PAIN (My whole body was hurting and) and HEADACHE (Had slight headache) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 076C21A, 013M20A and 041L20A) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure abnormal, Blood cholesterol abnormal and Anxiety. Concomitant products included CLONAZEPAM for Anxiety, BISOPROLOL FUMARATE, HYDROCHLOROTHIAZIDE (BISOPROLOL /HCTZ) and LISINOPRIL for Blood pressure abnormal, SIMVASTATIN for Cholesterol, VITAMIN D3 and CALCIUM CARBONATE (CALTRATE [CALCIUM CARBONATE]) for an unknown indication.   On 18-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 25-Oct-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 26-Oct-2021, the patient experienced PAIN (My whole body was hurting and) and HEADACHE (Had slight headache). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at a dose of 2 dosage form. At the time of the report, PAIN (My whole body was hurting and) and HEADACHE (Had slight headache) was resolving.            This case was linked to MOD-2021-365051 (Patient Link).
Soreness to the injection area initially. Later in the evening patient reported body and muscle aches for the next 36 hours.
started with shortness of breath when walking or going up stairs about 4 days after being vaccinated. Then 10 days after vaccination I woke up in the middle of the night with my heartrate at 175bpm. Ended up calling 911. After that the eleveated heartrate started happening every day and at different times. The shortness of breath became so bad that I couldn't go up stairs and even taking a shower started an episode. I couldn't drive or do much of anything. A heart monitor showed I have SVT and PVCs. I was put on beta blockers but couldn't tolerate. I am now on calcium channel blocker for past 3 months. I am slowly getting better.
Patient called reporting they had chills, fever, high pulse rate, heart palpitations, and headache.
Fever for 2 days, severe HA for 5 days, mother reports increase in his known short-term memory loss.
Post vax, the pt developed a severe reaction. Follow-up information from a registered nurse indicated that the reaction was not related to any medications but rather to a chronic underlying condition which was successfully treated. Subsequently, the pt recovered.
Phone call 7/21/07. c/o red area sz of half dollar. Warm to touch. Advised Tylenol. Call if sx. persist condition resolved itself.
This is a spontaneous report from a contactable pharmacist who reported for himself. This male patient of an unspecified age and race/ethnicity received PREVNAR 13, via an unspecified route of administration at single dose on an unspecified date for immunisation. The patient medical history and concomitant medications were not reported. The day after receiving the vaccine he feel a bit "clumsy" and after a few days he was diagnosed with pneumonia. The outcome of the events was unknown. Sender's Comments: Based on the information provided in the case, a lack of efficacy with PREVENAR 13 in this patient cannot be excluded. Further information like causative agent and serotyping results is needed for a full medical assessment.
Pt vaccinated with MMR/HIB developed temp >104 & tonic seizure, w/eyes deviated to left & mild cyanosis - seizure duration less than 2 min - postictal 15-20min. initial eval by MEDICS at childs home. Seen in office within 1 hr of incident.
Fever, Chills, Muscle Aches/Soreness, Profuse Sweating, Lethargy
12/4/2001 Immunized. 12/10/2001 Pain in deltoid area with swelling, redness 7 cm in area. 12/11/2001 Pain returned to shoulder, elbow, clavicle and shoulder blade. 12/13/2001 Saw MD.
Arm of injection feels really hot,arm turned red,arm swelled; This spontaneous case was reported by a consumer and describes the occurrence of CELLULITIS (Arm of injection feels really hot,arm turned red,arm swelled) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced CELLULITIS (Arm of injection feels really hot,arm turned red,arm swelled) (seriousness criterion medically significant). At the time of the report, CELLULITIS (Arm of injection feels really hot,arm turned red,arm swelled) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No Concomitant medications were reporter. Patient also experienced pain. No treatments were reported.  Company Comment: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Patient is a 60 year old female with PMH of HTN and HLD who presents with c/o cough. As per patient she had a head cold which started on Friday 12/24/21. Patient states that 2 days ago she developed a cough and that increased with any exertion to the extent that she felt as though she was choking. Patient denies chest pain, nausea, vomiting and diarrhea. Patient was vaccinated with Pfizer in February and March.   In the ED, pulse ox is 90% on RA and improved to 98% on O2 at 2L/min, temp is 101.6. Patient's rapid covid is negative. K 3.2, CRP 4.24, Ferritin 537, ESR 38. CXR is negative
unexpected bruising on LEs 5 days after report of receiving Janssen Covid vaccine at work
Has not received her 2nd dose; Arthritis is 10 times worse; Joints blew up; Fingertips blew up like a little balloon; Her toe broke open; It was bad; May have received "too much" of the vaccine; This spontaneous case was reported by a consumer and describes the occurrence of OVERDOSE (May have received "too much" of the vaccine), PRODUCT DOSE OMISSION ISSUE (Has not received her 2nd dose), ARTHRITIS (Arthritis is 10 times worse), JOINT SWELLING (Joints blew up) and PERIPHERAL SWELLING (Fingertips blew up like a little balloon) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Previously administered products included for Pneumonia: PNEUMO 23; for Flu: FLU VACCINE VII. Concurrent medical conditions included Type 1 diabetes mellitus and Rheumatoid arthritis. Concomitant products included NAPROXEN SODIUM (ALEVE) for an unknown indication.    On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Feb-2021, the patient experienced OVERDOSE (May have received "too much" of the vaccine), ARTHRITIS (Arthritis is 10 times worse), JOINT SWELLING (Joints blew up), PERIPHERAL SWELLING (Fingertips blew up like a little balloon), LIMB INJURY (Her toe broke open) and PAIN (It was bad). On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (Has not received her 2nd dose). The patient was treated with NAPROXEN SODIUM (ALEVE) at an unspecified dose and frequency. On 24-Feb-2021, OVERDOSE (May have received "too much" of the vaccine) had resolved. At the time of the report, PRODUCT DOSE OMISSION ISSUE (Has not received her 2nd dose) had resolved and ARTHRITIS (Arthritis is 10 times worse), JOINT SWELLING (Joints blew up), PERIPHERAL SWELLING (Fingertips blew up like a little balloon), LIMB INJURY (Her toe broke open) and PAIN (It was bad) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
After receiving my 2nd Pfizer COVID vaccine, I have been experiencing severe neck pain and tingling in my arm, shoulder,  and neck on the side where I was given the vaccine.   I have been taking Aleve muscle and back pain twice a day every day since March 29, 2021, and that really is not helping.   The pain seems to be lessening, but it is beyond difficult to sleep,  and being able to concentrate through the pain while working is difficult as well.
A purple welt several inches in area at the injection site was discovered by my wife last night -- actual onset may have been earlier.  Area was swollen and tender/sore.  This morning (3/14), the color had changed to red.
Patient developed subcutaneous nodule at site of vaccines in right thigh. Mother noticed nodule in week following vaccine administration, brought it to medical attention at 4 month check-up on 8/3/22
Woke up to chest pain 3.5 days after 2nd dose. Went to ER where elevated Troponin levels were found from bloodwork. Sent to another hospital in ambulance where I was put on a Heparin drip. After multiple tests (EKG, echocardiogram, CT scan) cardiologist diagnosed Myocarditis. Released from hospital after 2 days once they determined that the heart was healthy aside from the inflammation.
Patient states that after second dose of Pfizer vaccine, he developed shortness of breath and chest pain on Thursday (3 days after vaccination) that is still continuing, today on day 10.  He states it is persistent, was seen at urgent care and tested for COVID.  His result was negative, and he then was seen at the Hospital where he was discharged with meloxicam for his pain.  Patient was worked up at ED with no documented evidence or findings.
Information regarding Prevnar was received from a healthcare professional regarding a 5-month-old male patient who experienced pneumococcal meningitis and drug ineffective. The patient received the second dose approximately in October, 2006 at 4 months of age and the first dose was administered approximately in August, 2006 at 2 months of age. Blood culture (results: identified pneumococcal meningitis (serotype 7F) and CSF culture (results: identified pneumococcal meningitis (serotype 7F) were done in 2006. On 29-Nov-2006, the infant experienced pneumococcal meningitis. He was hospitalized. A spinal tap and blood culture showed pneumococcal meningitis, serotype 7F (not including among the Prevnar serotypes). The infant was visiting at the time of the event and was subsequently air lifted to a hospital closer to his home for the insertion if a PICC line 9date unknown) to complete the anti-infective therapy. He was not admitted to the hospital. Upon leaving the hospital, the physician noted that the infant was stable and the mother recently wrote to the physician and stated that her son was doing very well. No additional information was available at the time of this report.
The patient's daughter called to report her mother developed a swollen tongue the evening after her second covid vaccination. It was mild at first but progressed to the point that it was interfering with the patient's speech.  Her breathing was not affected.  The swelling did subside some when the patient took allergy medication.  I recommended the patient be seen by a doctor, and her daughter agreed, but the patient was not keen on seeking medical care.
Initial misuse report received from a healthcare professional on 04 September 2013. It was reported that, three child patients (No other information was provided regarding the patients) received ACTHIB with mixed sterile water diluents. No adverse event was reported. List of documents held by sender: none.
Reactions after first dose were chills headache tiredness fatigue. Reactions after second dose were fatigue  Next menstrual cycle in June longer and heavier and this has been repeating for July, August and September.
sudden sever headache followed by vomiting; numbness in hands followed by aching in arms which moved into legs; cold hands/feet; fever 101; administered acetminophen; symptoms subsided after a few hours then returned the next day as extreme fatigue; cold hands;fever 101.5; treated with acetimenophen; symptoms subsided then changed by this morning to sore throat and chest with occasional mild cough, no sputnam. fever has not returned as of 11:05 am.
This spontaneous report was received from a pharmacist referring to a patient of unknown age and gender. No information about the patient's medical history, concurrent conditions or concomitant medications was provided. On an unknown date, the patient was supposed to be vaccinated with a dose of PNEUMOVAX 23 for prophylaxis but instead was inadvertently administered with another dose of PREVNAR 13.  Other suspect therapies included PREVNAR 13. No adverse effects were reported and no product quality complaint was involved. Additional information has been requested.
Patient came in for her first dose of the COVID-19 vaccine. Patient given pediatric age 5-11 COVID-19 Pfizer vaccine dose instead of Pfizer COVID-19 age 12+ dose. Per guidelines dose does not need to be repeated. Patient should receive the Pfizer COVID-19 vaccine for age 12+ after 21 days to complete series. Patient's mother informed of error and of guidelines. She was given copy of guidelines.
24 hours after receiving the vaccine I had a fever, aches, and chills. 3 days after I came down with Posterior Vitreous Detachment in my eye. I went to the doctor on Monday 11/1/2021 to see an Ophthalmologist. They took a picture of my eye and looked at it. On 11/5/2021 I went to see a retinal specialist about my eye. They took pictures and did an eye test. Today I went to an Internist because my temple hurts a lot too. They will be doing blood work tomorrow.
Information has been received from a consumer concerning a her son who was vaccinated with a dose of MMR II. The reported stated that the child "got really sick" after the MMR II. Additional information is not expected.
Patient Experienced pain when receiving the vaccination and started shaking/fingers and fingernails started to turn blue. Recorded temperature was 97 and gave patient orange juice. Patient stayed in store for about 20 minutes and felt better. Shaking resolved but finger was still blue. Patient's father took son to medical facility afterwards.
His troponin peaked at 7.8, and waxed and waned over his stay. On day three, it steadily decreased to 1.2.  CRP was also elevated with a max at 5.3, but was <1 on discharge. He remained on telemetry throughout his stay, and had occasional pvcs but no true ectopy. Two echos and multiple EKGs were normal.  His chest pain resolved by HD 2 and he felt well after that.  He was started on high dose ibuprofen and pepsid, which he should remain on for a total of 7 days.